Your session is about to expire
← Back to Search
Cognitive Biomarker Development for Chronic Conditions
Study Summary
This trial is testing if it's possible to create biomarkers for cognitive function that can be applied across different diseases. They will be using TMS and electrophysiology on patients with chronic pain or depression, as well as healthy controls.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am experiencing pain or depression.You are pregnant.I am under 18 years old and do not speak English.
- Group 1: Pain/Depression patients from clinic
- Group 2: Healthy Comparison Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being included in this clinical research?
"Affirmative. The information from clinicaltrials.gov affirms that this medical study is currently recruiting participants, with 45 people being sought for the trial at one location. This research was first published on April 11th 2022 and recently revised on September 8th 2022."
Are there yet any vacancies accessible to participants in this trial?
"Affirmative. Currently, this study is open to enrolment and data hosted on clinicaltrials.gov confirms that the initial posting was made on April 11th 2022 with a subsequent edit occurring September 8th of the same year."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger